Marina Trusova

Marina Trusova


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2017 in Organic Chemistry Frontiers
Verified
Journal Article
Open access
PDF file
MMMaria A. Morozova
Maria A. Morozova
MYMekhman S. Yusubov
Mekhman S. Yusubov
BKBohumil Kratochvil
Bohumil Kratochvil
VEVáclav Eigner
Václav Eigner
ABAlexander A. Bondarev
Alexander A. Bondarev
PPPavel Postnikov
Pavel Postnikov
A new method of azide–alkyne cycloaddition (AAC) in the presence of Zn(OAc)2 as an inexpensive and environmentally friendly catalyst in neat water has been developed.

30 March 2018 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
PPPavel Petunin
Pavel Petunin
EMEkaterina Martynko
Ekaterina Martynko
MTMarina Trusova
Marina Trusova
MKMaxim Kazantsev
Maxim Kazantsev
TRTatyana Rybalova
Tatyana Rybalova
PPPavel Postnikov
Pavel Postnikov

12 July 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Shamil AkhmedovShamil Akhmedov
Shamil Akhmedov
SASergey Afanasyev
Sergey Afanasyev
MTMarina Trusova
Marina Trusova
PPPavel Postnikov
Pavel Postnikov
YRYulia Rogovskaya
Yulia Rogovskaya
SPSergey Popov
Sergey Popov
Atherosclerosis, a systematic degenerative disease related to the buildup of plaques in human vessels, remains the major cause of morbidity in the field of cardiovascular health problems, which are the number one cause of death globally. Novel atheroprotective HDL-mimicking chemically modified carbon-coated iron nanoparticles (Fe@C NPs) were produced by gas-phase synthesis and modified with organic functional groups of a lipophilic nature. Modified and non-modified Fe@C NPs, immobilized with polycaprolactone on stainless steel, showed high cytocompatibility in human endothelial cell culture. Furthermore, after ex vivo treatment of native atherosclerotic plaques obtained during open carotid endarterectomy surgery, Fe@C NPs penetrated the inner structures and caused structural changes of atherosclerotic plaques, depending on the period of implantation in Wistar rats, serving as a natural bioreactor. The high biocompatibility of the Fe@C NPs shows great potential in the treatment of atherosclerosis disease as an active substance of stent coatings to prevent restenosis and the formation of atherosclerotic plaques.

Verified
Journal Article
Open access
PDF file
Shamil AkhmedovShamil Akhmedov
Shamil Akhmedov
SASergey Afanasyev
Sergey Afanasyev
Natalia BeshchasnaNatalia Beshchasna
Natalia Beshchasna
MTMarina Trusova
Marina Trusova
Ivan V. StepanovIvan V. Stepanov
Ivan V. Stepanov
BKBoris Kozlov
Boris Kozlov
The high mortality rate caused by atherosclerosis makes it necessary to constantly search for new and better treatments. In previous reports, chemically modified carbon-coated iron nanoparticles (Fe@C NPs) have been demonstrated a high biocompatibility and promising anti-plaque properties. To further investigate these effects, the interaction of these nanoparticles with the adipose tissue of Wistar rats (in vivo) and human atherosclerotic plaques (ex vivo) was studied. For the in vivo study, cobalt–chromium (CoCr) alloy tubes, which are used for coronary stent manufacturing, were prepared with a coating of polylactic acid (PLA) which contained either modified or non-modified Fe@C NPs in a 5% by weight concentration. The tubes were implanted into an area of subcutaneous fat in Wistar rats, where changes in the histological structure and functional properties of the surrounding tissue were observed in the case of coatings modified with Fe@C NPs. For the ex vivo study, freshly explanted human atherosclerotic plaques were treated in the physiological solution with doses of modified Fe@C NPs, with mass equal to 5% or 25% relative to the plaques. This treatment resulted in the release of cholesterol-like compounds from the surface of the plaques into the solution, thus proving a pronounced destructive effect on the plaque structure. Chemically modified Fe@C NPs, when used as an anti-atherosclerosis agent, were able to activate the activity of macrophages, which could lead to the destruction of atherosclerotic plaques structures. These findings could prove the fabrication of next-generation vascular stents with built-in anti-atherosclerotic agents.

4 June 2016 in Russian Physics Journal
Verified
Journal Article
Closed access
PDF file
RVR. R. Valiev
R. R. Valiev
ADA. K. Drozdova
A. K. Drozdova
PPPavel Petunin
Pavel Petunin
PPPavel Postnikov
Pavel Postnikov
MTMarina Trusova
Marina Trusova
VCV. N. Cherepanov
V. N. Cherepanov

1 September 2014 in Advanced Materials Research
Verified
Journal Article
Closed access
PDF file
NSN.S. Surgutskaya
N.S. Surgutskaya
PPPavel Postnikov
Pavel Postnikov
APAlexandra G. Pershina
Alexandra G. Pershina
AGA.I. Galanov
A.I. Galanov
MTMarina Trusova
Marina Trusova
ASAlexey E. Sazonov
Alexey E. Sazonov
The Fe-core/carbon-shell nanopowders are excellent platform for covalent grafting of biomolecules. The large-scale synthesis of Fe-core/carbon-shell nanoparticles via electropulse erosion of metal precursors in hydrocarbons was developed. The green fluorescent protein was covalently attached to the powder surface via diazonium functionalization and further carbodiimide activation.